Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.78 USD | -2.69% | -6.47% | -13.10% |
May. 16 | Transcript : Syndax Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM | |
May. 15 | Syndax Pharmaceuticals, Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2024 * | 31.52M | Sales 2025 * | 108M | Capitalization | 1.6B |
---|---|---|---|---|---|
Net income 2024 * | -307M | Net income 2025 * | -269M | EV / Sales 2024 * | 49.3 x |
Net cash position 2024 * | 44.29M | Net cash position 2025 * | 203M | EV / Sales 2025 * | 12.9 x |
P/E ratio 2024 * |
-5.28
x | P/E ratio 2025 * |
-6.44
x | Employees | 184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.15% |
Latest transcript on Syndax Pharmaceuticals, Inc.
1 day | -2.69% | ||
1 week | -6.47% | ||
Current month | -2.54% | ||
1 month | -14.83% | ||
3 months | -19.40% | ||
6 months | +12.46% | ||
Current year | -13.10% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 15-05-04 |
Peter Ordentlich
FOU | Founder | 55 | 05-10-10 |
Neil Gallagher
PSD | President | 60 | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 17-03-28 |
Dennis Podlesak
CHM | Chairman | 66 | 08-11-30 |
Pierre Legault
BRD | Director/Board Member | 63 | 17-01-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% | ||
0.06% | 1,487 M€ | +7.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 18.82 | -2.49% | 883,149 |
24-06-03 | 19.3 | +0.16% | 1,604,169 |
24-05-31 | 19.27 | -0.10% | 844,553 |
24-05-30 | 19.29 | -2.18% | 1,993,849 |
24-05-29 | 19.72 | -1.79% | 934,829 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.10% | 1.6B | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.19% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- SNDX Stock